Not-So-Rare Defects of RBC Lipidic Composition: Four New Cases of Flippase Deficiency Due to ATP11C Mutations
Authors:
- Elisa FermoEFElisa Fermo
- Elena TrombettaETElena Trombetta
- Anna Paola MarcelloAMAnna Paola Marcello
- Cristina VercellatiCVCristina Vercellati
- Giulia Maria FerrariGFGiulia Maria Ferrari
- Anna ZaninoniAZAnna Zaninoni
- Valentina BrancaleoniVBValentina Brancaleoni
- Elena Di PierroElena Di Pierro
- Sara BeneventiSBSara Beneventi
- Marta TorneseMTMarta Tornese
- Bruno FattizzoBFBruno Fattizzo
- Tommaso CasiniTCTommaso Casini
Open Access
- 10 August 2025
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7722
Abstract
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (ATP11C), located on the X chromosome, encodes the major phosphatidylserine flippase in human erythroid cells. Only five patients have so far been reported with defective ATP11C, displaying mild hemolytic anemia and reduced flippase activity. In this study, we report four Italian male patients in three unrelated families with novel private mutations in the ATP11C gene, resulting in impaired flippase activity associated with mild/compensated hemolytic anemia. The decreased flippase activity was measured as % of phosphatidylserine internalization over time and ranged after 20 min incubation from 5% to 18.6% in all patients, regardless of the type of molecular defect. Flippase activity was also tested in healthy controls, ranging from 43% to 62% in both males and females. This measurement appears to be a useful tool for hypothesizing ATP11C abnormalities in male subjects with mild compensated hemolysis, prior to next generation sequencing (NGS) analysis. Although rare, ATP11C mutations may be underrecognized, and therefore should be suspected and investigated in male patients presenting with subtle hemolytic signs or symptoms.Keywords
Funding Information
- Italian Ministry of Health—Current research IRCCS, Fondazione IRCCS Ca’ Granda Policlinico Milano (RC2024 175/01, 101120168)
- European Union’s MASCA Horizon 2020 acronym INNOVATION (RC2024 175/01, 101120168)
- European Reference Network on Rare Hematological Diseases (ERN-EuroBloodNet) (RC2024 175/01, 101120168)
This publication has 36 references indexed in Scilit:
- Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendationsCell Death & Disease, 2025
- Crossing the membrane—What does it take to flip a phospholipid? Structural and biochemical advances on P4-ATPase flippasesJournal of Biological Chemistry, 2024
- Apoptosis and eryptosis: similarities and differencesApoptosis, 2023
- A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemiaAmerican Journal of Hematology, 2023
- Phosphatidylserine transport in cell life and deathCurrent Opinion in Cell Biology, 2023
- ATP11C T418N, a gene mutation causing congenital hemolytic anemia, reduces flippase activity due to improper membrane traffickingBiochemical and Biophysical Research Communications, 2019
- Rare Hereditary Hemolytic AnemiasHematology/Oncology Clinics of North America, 2019
- The assessment of noncoding variant of PPOX gene in variegate porphyria reveals post-transcriptional role of the 5′ untranslated exon 1Blood Cells, Molecules, and Diseases, 2016
- Surface exposure of phosphatidylserine in pathological cellsCellular and Molecular Life Sciences, 2005
- Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells.Journal of Biological Chemistry, 1994